RESEARCH TRIANGLE PARK, N.C., May 14, 2024 (GLOBE NEWSWIRE) -- BioCryst Pharmaceuticals Inc. (Nasdaq: BCRX) today announced that new data…
Surpasses its goal of reaching 25 million women by 2025RAHWAY, NJ / ACCESSWIRE / May 8, 2024 / Merck (NYSE:MRK),…
Surpasses its goal of reaching 25 million women by 2025RAHWAY, NJ / ACCESSWIRE / May 8, 2024 / Merck (NYSE:MRK),…
-- Recruitment of the commercial team for our infertility portfolio and the pivotal trial of FemBloc® for permanent non-surgical birth…
Following Nuvo’s NASDAQ Listing, Addition of Machado Brings Strong Health and Impact Experience to Remote Pregnancy Monitoring PioneerTEL AVIV, Israel,…
CUPERTINO, Calif.--(BUSINESS WIRE)--ARC Fertility (ARC), a highly experienced national provider of innovative fertility and family-forming benefits for self-insured employers and…
Team to Drive Strategic Initiatives, Launching Efforts at 2024 ACOG MeetingATLANTA, May 07, 2024 (GLOBE NEWSWIRE) -- Femasys Inc. (Nasdaq:…
MIAMI, FL, May 02, 2024 (GLOBE NEWSWIRE) -- Veru Inc. (NASDAQ: VERU), a late clinical stage biopharmaceutical company focused on…
Trial planning and execution to proceed as planned WASHINGTON, May 02, 2024 (GLOBE NEWSWIRE) -- 60 Degrees Pharmaceuticals, Inc. (NASDAQ: SXTP;…
Ovaterra's new formula is the first prenatal vitamin in the U.S. market to provide 100% of the essential nutrients a…